spondyloarthritis

This page shows the latest spondyloarthritis news and features for those working in and with pharma, biotech and healthcare.

UCB supports social network for SpA patients

MySpondylitisTeam is launched by MyHealthTeams. UCB has partnered with MyHealthTeams to launch a new social network called MySpondylitisTeam for patients with the chronic and inflammatory arthritis spondyloarthritis (SpA). ... Eric Peacock, co-founder

Latest news

Lilly pilots enhanced online trial information

The pilot project has so far been added to two clinical trials, a study of Taltz (ixekizumab) in non-radiographic axial spondyloarthritis and one of Cialis (tadalafil) in pediatric patients with
NOR-SWITCH - the final piece in the biosimilar puzzle?

The patient populations for each indication were: 155 Crohn's disease, 93 ulcerative colitis, 78 rheumatoid arthritis, 91 spondyloarthritis, 30 psoriatic arthritis and 35 plaque psoriasis.
Novartis says Cosentyx is 'outpacing competitors'

Already approved for psoriasis, psoriatic arthritis (PsA) and ankylosing spondylitis (AS), Novartis has a pivotal trial in non-radiographic axial spondyloarthritis on-going as well as head-to-head superiority trials
Multiplicity

radiographic axial spondyloarthritis and plaque psoriasis in the EU.
Biogen-Samsung's Enbrel biosimilar cleared for EU marketing

The European Commission approved Samsung Bioepis' Benepali version of Enbrel (etanercept) for the treatment of adults with moderate to severe rheumatoid arthritis, psoriatic arthritis, non-radiographic axial spondyloarthritis and plaque psoriasis.

More from news
Approximately 3 fully matching, plus 9 partially matching documents found.

Latest from PMHub

Lucid Group make the cut at the PMEAs 2017

Category: Supporting Patients and Professionals. DUET: Harnessing the Power of Collaboration from Concept to Completion – Improving Patient Care in Spondyloarthritis, by AbbVie, with support from Lucid Group.
Infographic: Spondyloarthritis

Overview of spondyloarthritis patient profiles and treatment pathways. Spondyloarthritis is the name for a family of arthritis causing inflammatory rheumatic diseases; including axial spondyloarthritis, psoriatic arthritis and akylosing spondylitis,
Research Partnership

Infographic: Spondyloarthritis. ... Overview of spondyloarthritis patient profiles and treatment pathways.

More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Senior Account Manager, Rare Diseases – Medical Communications, ...: Excellent package

Medical Writer: Salary TBC

Account Manager / Account Director: Competative

Home-based Senior Project Manager – Independent Med Ed: Salary TBC

Associate Director: £75, 000-90, 000

Senior Account Manager: Competitive Salary Offered

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Account Director – Health Policy – Global Agency: Salary TBC

Client Services Director – Medical Education Agency – North West...: Salary TBC

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Account Manager / Senior Account Manager: 35, 000-40, 000

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Senior Medical Writer: Salary TBC

Account Director, Medical Education: Salary TBC

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Business Director: Competitive Salary Offered

Engagement Expert, Healthcare Brand Communications, London: Excellent package

Account Director: Competitive Salary Offered

Account Director – Healthcare Marketing – Berks: Salary TBC

Account Director, Healthcare Marketing Agency: Salary TBC

Senior Account Director development role to Business Director, H...: Excellent package

Global Business Development Director – Health Education: excellent commission

Subscribe to our email news alerts

PMHub

Add my company

OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

China’s clinical trial shake-up: As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?: Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement: Pharma has agreed to capped growth again - in exchange for uptake promises...